✦ LIBER ✦

1126 Prediction of Treatment Failures in Induction of Remission With Oral Mesalamine in Mild-to-Moderately Active Ulcerative Colitis

✍ Scribed by Wolfgang Kruis; Ralph Mueller; Roland Greinwald

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Once- or Twice-Daily MMX Mesal

✍ Lichtenstein, Gary R.; Kamm, Michael A.; Boddu, Prabhakar; Gubergrits, Natalya; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 488 KB

847t Adalimumab for Induction of Clinica

✍ Walter Reinisch; William J. Sandborn; Daniel W. Hommes; Geert R. D'Haens; Stephe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 185 KB

W1328 MMX® Mesalamine 2.4g/Day Maintains

✍ Kane, Sunanda V.; Solomon, Dory M.; Palmen, Mary; Barrett, Karen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

MMX mesalazine for the induction of remi

✍ G. R. LICHTENSTEIN; M. A. KAMM; W. J. SANDBORN; A. LYNE; R. E. JOSEPH 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

P104 Adalimumab for induction of clinica

✍ Gonzalez, F.; Cortes, T.; Ramos, M. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 67 KB

W1329 Patients With Mild-to-Moderate Ulc

✍ Kane, Sunanda V.; Solomon, Dory M.; Palmen, Mary; Barrett, Karen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB